Editors’ choiceA cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011
Section snippets
Background
The high prevalence of HIV among people who inject drugs (PWID) contributes substantially to global mortality rates (Degenhardt & Hall, 2012). Worldwide, 30% of HIV infections outside of sub-Saharan Africa are caused by injection drug use (International Harm Reduction Association [IHRA], 2012). It is estimated that between 11 and 21.2 million people inject drugs of which between .8 and 6.6 million are infected with HIV (Mathers et al., 2008). Numerous scientific studies—including reports by The
Data and measures
Data for this study were extracted from several publically available sources. The World Health Organization (WHO) Regional Office for Europe, and the European Center for Disease Control (ECDC) jointly compile HIV/AIDS surveillance data on the number of new cases of HIV infection in the general population for all 53 nations in the WHO European Region from 1985 to the present (World Health Organization [WHO], 2015). Annual numbers of new HIV cases for the 28 countries included in this study were
Results
Table 1 presents descriptive statistics and means for each country and the overall sample. The mean overall incidence rate of HIV was 5.70 (.40–30) (per 100,000 of the population) from 1995 to 2011. The numbers within parentheticals in Table 1 for both the overall population and PWID embody the minimum and maximum incidence rates of HIV for each country and the entire sample of countries over the time period from 1995 to 2011. Among PWID, the mean overall incidence rate of HIV was 123.04
Discussion
The central aim of this exploratory study was to examine the association between harm reduction programs and incidence rates of HIV in both the general population and PWID in Europe.
Conclusion
Given the absence of cross-national analyses of correlates of HIV incidence rates, this study opens the door to a new approach to studying the effects of harm reduction policies globally. Our findings reinforce extant literature suggesting that MMT and NSP implementation not only protects the basic human rights and health of PWID, but also promotes the health and wellbeing of societies at large by virtue of reducing overall rates of HIV.
Acknowledgements
Phillip L. Marotta was supported by a T-32 Training Grant from the National Institute on Drug Abuse (NIDA) Grant #: 1T32DA037801-01 during the writing and analysis of this research report. The authors gratefully acknowledge the support provided by Irwin Garfinkel, Neeraj Kaushal, Elwin Wu and Nabila El-Bassel.
Conflict of interest statement
The authors of this manuscript have no conflicts of interest to declare.
References (63)
- et al.
Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions
Drug and Alcohol Dependence
(2011) Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings
International Journal of Drug Policy
(2010)- et al.
Beyond the biomedical and behavioural: Towards an integrated approach to HIV prevention in the southern African mining industry
Social Science & Medicine
(1999) - et al.
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
The Lancet
(2012) - et al.
Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed
The Lancet
(2010) - et al.
Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups
International Journal of Drug Policy
(2007) - et al.
Modelling emerging HIV epidemics: The role of injecting drug use and sexual transmission in the Russian Federation, China and India
International Journal of Drug Policy
(2003) - et al.
Public financing of health in developing countries: A cross-national systematic analysis
The Lancet
(2010) - et al.
Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness
International Journal on Drug Policy
(2014) - et al.
Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review
The Lancet
(2008)
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
The Lancet
Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment
Social science & Medicine
The ‘risk environment’: A framework for understanding and reducing drug-related harm
International Journal of Drug Policy
Drug abuse treatment as an HIV prevention strategy: a review
Drug and Alcohol Dependence
HIV and risk environment for injecting drug users: The past, present, and future
The Lancet
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine
PLoS Medicine
Police encounters among needle exchange clients in Baltimore: Drug law enforcement as a structural determinant of health
American Journal of Public Health
Structural interventions for HIV prevention among women who use drugs: A global perspective
Journal of Acquired Immune Deficiency Syndromes
Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities
Addiction
Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment
Science
The diffusion of harm reduction in Europe and beyond
Game changers: Why did the scale-up of HIV treatment work despite weak health systems?
Journal of Acquired Immune Deficiency Syndromes
Harm reduction – A framework for incorporating science into drug policy
American Journal of Public Health
Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV
AIDS
Scale-up of HIV care and treatment: Can it transform healthcare services in resource-limited settings?
AIDS
Harm reduction in Europe: Mapping coverage and civil society advocacy
Discriminating needle exchange attenders from non-attenders
Addiction
Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users
AIDS
Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: A study of two cohorts
PLoS Medicine
The global state of harm reduction 2012: Towards an integrated response
Cited by (8)
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence
2020, International Journal of Drug PolicyCould 30 years of political controversy on needle exchange programmes in Sweden contribute to scaling-up harm reduction services in the world?
2021, NAD Nordic Studies on Alcohol and Drugs21<sup>st</sup> century cures for the opioid crisis: Promise, impact, and missed opportunities
2018, American Journal of Law and Medicine